Trial Profile
Study of ticagrelor short-term clinical in Patients With Non-Clopidogrel Resistance After Percutaneous Coronary Intervention
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 15 Sep 2016
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Coronary artery disease
- Focus Therapeutic Use
- 15 Sep 2016 New trial record